Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Actuate Therapeutics Inc.
Artios Pharma Ltd
Johns Hopkins University
Swiss Cancer Institute
Revolution Medicines, Inc.
Case Comprehensive Cancer Center
Pfizer
Asana BioSciences
NSABP Foundation Inc
Grupo Espanol Multidisciplinario del Cancer Digestivo
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Seagen Inc.